BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12135031)

  • 1. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease.
    Peterson CG; Eklund E; Taha Y; Raab Y; Carlson M
    Am J Gastroenterol; 2002 Jul; 97(7):1755-62. PubMed ID: 12135031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
    Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
    Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated fecal levels of eosinophil granule proteins predict collagenous colitis in patients referred to colonoscopy due to chronic non-bloody diarrhea.
    Wagner M; Sjöberg K; Vigren L; Olesen M; Benoni C; Toth E; Carlson M
    Scand J Gastroenterol; 2016 Jul; 51(7):835-41. PubMed ID: 26854205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: a pilot study.
    Wagner M; Peterson CG; Stolt I; Sangfelt P; Agnarsdottir M; Lampinen M; Carlson M
    Scand J Gastroenterol; 2011 Jul; 46(7-8):849-54. PubMed ID: 21557718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.
    Bischoff SC; Mayer J; Nguyen QT; Stolte M; Manns MP
    Am J Gastroenterol; 1999 Dec; 94(12):3521-9. PubMed ID: 10606314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT.
    Ekberg-Jansson A; Andersson B; Bake B; Boijsen M; Enanden I; Rosengren A; Skoogh BE; Tylén U; Venge P; Löfdahl CG
    Respir Med; 2001 May; 95(5):363-73. PubMed ID: 11392577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis.
    Nielsen OH; Gionchetti P; Ainsworth M; Vainer B; Campieri M; Borregaard N; Kjeldsen L
    Am J Gastroenterol; 1999 Oct; 94(10):2923-8. PubMed ID: 10520846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte markers in induced sputum in patients with respiratory disorders and healthy persons obtained by two sputum-processing methods.
    Metso T; Rytilä P; Peterson C; Haahtela T
    Respir Med; 2001 Jan; 95(1):48-55. PubMed ID: 11207017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls.
    Bischoff SC; Grabowsky J; Manns MP
    Dig Dis Sci; 1997 Feb; 42(2):394-403. PubMed ID: 9052525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in inflammatory markers following treatment of acute exacerbations of obstructive pulmonary disease.
    Dahlén I; Janson C; Björnsson E; Stålenheim G; Peterson CG; Venge P
    Respir Med; 2001 Nov; 95(11):891-7. PubMed ID: 11716203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell specific markers for eosinophils and neutrophils in sputum and bronchoalveolar lavage fluid of patients with respiratory conditions and healthy subjects.
    Metso T; Venge P; Haahtela T; Peterson CG; Sevéus L
    Thorax; 2002 May; 57(5):449-51. PubMed ID: 11978925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of intracellular markers in induced sputum and bronchoalveolar lavage samples in patients with respiratory disorders and healthy persons.
    Metso T; Haahtela T; Sevéus L
    Respir Med; 2002 Nov; 96(11):918-26. PubMed ID: 12418590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion.
    Carlson M; Raab Y; Peterson C; Hällgren R; Venge P
    Am J Gastroenterol; 1999 Jul; 94(7):1876-83. PubMed ID: 10406252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil markers in seasonal allergic rhinitis. Intranasal fluticasone propionate inhibits local and systemic increases during the pollen season.
    Nielsen LP; Bjerke T; Christensen MB; Skamling M; Peterson CG; Mygind N; Dahl R
    Allergy; 1998 Aug; 53(8):778-85. PubMed ID: 9722227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased fecal eosinophil cationic protein in inflammatory bowel disease.
    Berstad A; Børkje B; Riedel B; Elsayed S; Berstad A
    Hepatogastroenterology; 1993 Jun; 40(3):276-8. PubMed ID: 8325594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilic airway inflammation as an underlying mechanism of undiagnosed prolonged cough in primary healthcare patients.
    Rytilä P; Metso T; Petäys T; Sohlman A; Työlahti H; Kohonen-Jalonen P; Kiviniemi P; Haahtela T
    Respir Med; 2002 Jan; 96(1):52-8. PubMed ID: 11863210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A kinetic study in adults with food hypersensitivity assessed as eosinophil activation in fecal samples.
    Magnusson J; Gellerstedt M; Ahlstedt S; Andersson B; Bengtsson U; Telemo E; Hansson T; Peterson CG
    Clin Exp Allergy; 2003 Aug; 33(8):1052-9. PubMed ID: 12911778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Schistosoma mansoni induced intestinal inflammation by means of eosinophil cationic protein, eosinophil protein X and myeloperoxidase before and after treatment with praziquantel.
    Reimert CM; Tukahebwa EM; Kabatereine NB; Dunne DW; Vennervald BJ
    Acta Trop; 2008 Mar; 105(3):253-9. PubMed ID: 18177822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed.
    Blom K; Rubin J; Halfvarson J; Törkvist L; Rönnblom A; Sangfelt P; Lördal M; Jönsson UB; Sjöqvist U; Håkansson LD; Venge P; Carlson M
    World J Gastroenterol; 2012 Nov; 18(44):6409-19; discussion p. 6417-8. PubMed ID: 23197886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents.
    Hällgren R; Colombel JF; Dahl R; Fredens K; Kruse A; Jacobsen NO; Venge P; Rambaud JC
    Am J Med; 1989 Jan; 86(1):56-64. PubMed ID: 2535919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.